OP01 [Mar96] With regards to pethidine s physical properties: A. It has an octanol coefficient of 10 B. It has a pka of 8.4

Similar documents
Agonists: morphine, fentanyl Agonists-Antagonists: nalbuphine Antagonists: naloxone

6/6/2018. Nalbuphine: Analgesic with a Niche. Mellar P Davis MD FCCP FAAHPM. Summary of Advantages. Summary of Advantages

Merja Kokki MD, PhD Department of Anaesthesiology and Intensive Care, Kuopio University Hospital, School of Medicine, University of Eastern Finland

Opioid Pharmacology. Dr Ian Paterson, MA (Pharmacology), MB BS, FRCA, MAcadMEd. Consultant Anaesthetist Sheffield Teaching Hospitals

Pharmacokinetics of strong opioids. Susan Addie Specialist palliative care pharmacist

Drugs Used In Management Of Pain. Dr. Aliah Alshanwani

OPIOIDS. Dr S Walton Eastbourne DGH 2012

Methadone Maintenance

Pharmacogenetics of Codeine. Lily Mulugeta, Pharm.D Office of Clinical Pharmacology Pediatric Group FDA

Analgesics OPIOID ANALGESICS

b. Explain the structure-activity relationships of the opioid agonists and antagonists. HO

Analgesia is a labeled indication for all of the approved drugs I will be discussing.

Clinical pharmacological aspects of heroin and fentanyl overdoses

POLICY and PROCEDURE

PAIN & ANALGESIA. often accompanied by clinical depression. fibromyalgia, chronic fatigue, etc. COX 1, COX 2, and COX 3 (a variant of COX 1)

Slide 1. Slide 2. Slide 3. Opioid (Narcotic) Analgesics and Antagonists. Lesson 6.1. Lesson 6.1. Opioid (Narcotic) Analgesics and Antagonists

Analgesic Drugs PHL-358-PHARMACOLOGY AND THERAPEUTICS-I. Mr.D.Raju,M.pharm, Lecturer

Analgesia for Patients with Substance Abuse Disorders. Lisa Jennings CN November 2015

THE OPIUM POPPY OPIOID PHARMACOLOGY 2/18/16. PCTH 300/305 Andrew Horne, PhD MEDC 309. Papaver somniferum. Poppy Seeds Opiates

OST. Pharmacology & Therapeutics. Leo O. Lanoie, MD, MPH, FCFP, CCSAM, ABAM, MRO

Prescription Pain Management. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita 1 Narciso Pharm D

Postoperative Pain Management. Nimmaanrat S, MD, FRCAT, MMed (Pain Mgt)

POST-INTUBATION ANALGESIA AND SEDATION. August 2012 J Pelletier

GOALS AND OBJECTIVES

WR Fentanyl Symposium. Opioids, Overdose, and Fentanyls

Dr. Hiwa K. Saaed. PhD Pharmacology & Toxicology College of Pharmacy, University of Sulaimani Analgesic

Buprenorphine pharmacology

Appendix D: Drug Tables

Acute Pain Management in the Hospital Setting. Alexandra Phan, PharmD PGY-1 Pharmacy Practice Resident Medical Center Hospital Odessa, TX

TRAPADOL INJECTION FOR I.V./I.M. USE ONLY

General Pharmacology MCQs

Multi Modal Analgesia

Clinical Guideline. Guidelines for the use of opioid analgesics in the management of acute pain in adults

Substitution Therapy for Opioid Use Disorder The Role of Suboxone

Acute Pain Management

DBL NALOXONE HYDROCHLORIDE INJECTION USP

Fentanyls and Naloxone. Opioids, Overdose, and Naloxone

Sedation For Cardiac Procedures A Review of

Mitigating Risks While Optimizing the Benefits of Pharmacologic Agents to Manage Pain in the Elderly

Screening - inclusion criteria

Karam Darwish. Dr. Munir. Munir Gharaibeh

Screening - inclusion criteria

Nalbuphine morphine cross reactivity

3/15/2018. Pain. Pain. Opioid Analgesics Addiction. Pain

Use of methadone in young animals, geriatric animals, and those with concurrent disease

GUIDELINES AND AUDIT IMPLEMENTATION NETWORK

Sign up to receive ATOTW weekly -

Pharmacology of Selected Opioid Analgesics

Opioids. Robin Moorman Li I. OVERVIEW II. OPIOID RECEPTORS

What is an opioid? What do opioids do? Why is there an opioid overdose crisis? What is fentanyl? What about illicit or bootleg fentanyls?

XTRAM. Composition Xtram 50 mg capsule Each capsule contains Tramadol HCl 50 mg

disease or in clients who consume alcohol on a regular basis. bilirubin

LONG TERM PHARMACOTHERAPY OF OPIOID DEPENDENCE

Opioids- Indica-ons, Equivalence, Dependence and Withdrawal Methadone Maintenance (OST) Paul Glue

PALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST

PERIOPERATIVE PAIN MANAGEMENT: WHAT S UP WITH METHADONE?

Overview of Essentials of Pain Management. Updated 11/2016

Cytochrome P450 Drug Interaction Table Flockhart Table

OPIOIDS. Testing and Interpretation

BACKGROUND Measuring renal function :

PARACOD Tablets (Paracetamol + Codeine phosphate)

Ideal Sedative Agent. Benzodiazepines 11/12/2013. Pharmacology of Benzodiazepines Used for Conscious Sedation in Dentistry.

Ideal Sedative Agent. Pharmacokinetics. Benzodiazepines. Pharmacodynamics 11/11/2013

Pain Management Strategies Webinar/Teleconference

Pain Management in the Surgical Patient. Peter Vogel, VMD, DACVS

Opioids: Use, Abuse and Cause of Death. Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory

B. Long-acting/Extended-release Opioids

4.4 Special warnings and precautions for use

Local anaesthetics. Dr JM Dippenaar

Review Polyanalgesic Consensus Charles Brooker Royal North Shore Hospital

Which is stronger 100 mg. tramadol or 5 mg oxycodone

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)

Summary of risk management plan for Dzuveo (Sufentanil (as citrate))

OPIATES AND ADDICTION MEDICATIONS. Dr. Carroll W. Thornburg, D.O Chief Medical Officer in Primary Care and Addiction Services

Case Study: Opiates use for Anesthesia & analgesia

An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT

Opioids. Sergio Hernandez, MD

Pharmacology of Selected Opioid Analgesics

Dr M H Mosaddegh Pharm D, PhD

Pain Management Management in Hepatic Hepatic and and Renal Dysfunction

Optimizing Suboxone in Opioid Addicts

BJF Acute Pain Team Formulary Group

BEHAVIOURAL SCREENING OF DRUGS HYPNOTICS/SEDATIVES

WORRIED ABOUT PAIN AFTER ORAL SURGERY?

Dsuvia (sufentanil) NEW PRODUCT SLIDESHOW

Opioid Use in Youth. Amy Yule M.D. March 2,

Opioid Toxicity - Objectives. Opioid Toxicity: A Poison Center. and Pediatric Perspective. Greatest Increase is Exposures

WESTMEAD PRIMARY EXAM GROUP PSYCHOTROPIC MEDICATIONS

Chapter 25. General Anesthetics

DRUGS THAT ACT IN THE CNS

Opioid Overdose Best Practices Guideline. Table of Contents. A. General description: B: Typical signs and symptoms:

Acute Pain NETP: SEPTEMBER 2013 COHORT

CHAMP: Bedside Teaching TREATING PAIN. Stacie Levine MD. What is the approach to treating pain in the aging adult patient?

General Anesthesia. Mohamed A. Yaseen

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

The WHY and HOW of Acute Pain Control

Associate Professor Supranee Niruthisard Department of Anesthesiology Faculty of Medicine Chulalongkorn University January 21, 2008

Steven Prakken MD Director Medical Pain Service Duke Pain Medicine

Respiratory Depression

Transcription:

Opioid MCQ OP01 [Mar96] With regards to pethidine s physical properties: A. It has an octanol coefficient of 10 B. It has a pka of 8.4 OP02 [Mar96] Which factor does NOT predispose to bradycardia with fentanyl in doses of 50 mcg/kg? A. Calcium channel antagonist B. Beta-blocker C. Benzodiazepines E. Slow injection of drug OP03 [Mar96] [Mar99] [Jul99] [Feb00] [Apr01] Naloxone: A. Is not an antagonist of agonist-antagonist drugs B. Is not an antagonist at?mu & sigma receptors C. Causes pulmonary oedema D. Can cause hypotension in experimental shock animal models E. May cause an abrupt increase in sympathetic tone OP03b [Mar97] Naloxone: A. Is effective at antagonising a full agonist but not a partial agonist B. Causes pulmonary oedema C.? D.? OP04 [Mar96] [Jul99] {Diagram of numbered structure of morphine} Which substitutions correct? A. N17 substitution gives antagonist activity B. C6 methylation produces codeine C. Glucuronidation occurs at C2 D. Diacetylation decreases lipid solubility Also remembered as: Morphine base structure with questions about substitutions A. C3 and C6 increase lipid solubility B. Acetyl group on C3 gives heroine C. N- substitution gives antagonist D. C5 glucuronidation site E. C3 methyl gives codeine OP05 [Mar96] [Jul98] [Jul00] Pethidine in doses of 2 to 2.5 mg/kg causes all of the following EXCEPT: A. Bradycardia B. Decreased systemic vascular resistance C.?Normal arterial BP /?decreased BP D. Increased cardiac output OP06 [Mar96] Regarding the clearance of morphine: A. Affected by cirrhosis B. Affected by hepatic blood flow

C. Shows low hepatic extraction ratio OP07 [Jul97] [Mar99] [Jul99] [Jul00] [Feb04] [Jul04] Fentanyl: A. With pka 8.4 is 90% ionised at physiological ph B. Has an octanol coefficient of 10 C. Is 1,000 times more potent than morphine D. Has first-pass lung uptake reduced to 20% by propranolol E. Has up to 50% uptake in the lung (up to 75% pulmonary uptake) F. Elimination half-life < 2 hour G. Carried on albumin mostly (Xenobiotica, March 2015, Vol. 45, No. 3 : Pages 207-212) H. Carried on alpha-1 acid glycoprotein mostly I. Can cause hypertension with MAOI J. Alfentanil acts faster as it has a higher unionised, unbound fraction OP08 [Jul97] An opioid which can not be used for TIVA: A. Morphine B. Pethidine C. Fentanyl D. Sufentanil E. Alfentanil OP10 [Mar98] Pethidine A. 100mg is equal to 10mg morphine in effect B. Increases heart rate C. No effect on cardiac output D. Is preferred to morphine for analgesia OP10b [Mar98] Pethidine produces: A. Miosis (less than other opioids) B. More severe hypotension with comparable dose of morphine C. More biliary spasm than morphine (less) OP11 [Mar98] TIVA with morphine causes the following EXCEPT: A. Mydriasis B. Muscle rigidity C. Respiratory depression OP12 [Mar98] [Jul98] [Jul02] [Mar03] Codeine: A. Substitution at C6 position of morphine B. 10% of codeine is metabolised to diacetyl morphine C. IM 100mg is equivalent to 10 mg morphine D. Methyl substitution at the?c5/?c6 position of morphine E. Can be safely given IV because causes no histamine release F. Has higher first pass effect than morphine OP13 [Jul98] Morphine metabolism: A. Principally metabolised to morphine-6-glucuronide B. Metabolites have shorter half-life C. Found in extrahepatic sites D. Metabolites freely cross the blood-brain barrier

E. Metabolites all have analgesic effect F. In neonates, predominantly by sulphation G. In adults, mostly to morphine-3-glucuronide OP15 [Mar99] [Feb00] [Jul02] Sufentanil: A. 30 times as potent as fentanyl B. < 7% excreted unchanged in urine C. Greater protein binding than fentanyl D. Half-life of elimination between fentanyl & alfentanil E. Predominantly bound by?albumin/? alpha1-acid glycoprotein OP16 [Mar99] [Jul00] Pethidine is the traditionally favoured opioid in obstetrics because: A. Norpethidine does not cross the placenta B. Does not undergo ion trapping C. Causes less neonatal depression D. It does not cross the placenta E. It is thought to cause less respiratory depression in the neonate. OP17 [Mar99] Pethidine: A. Better bioavailability than codeine (not true, similar OBA) OP18 [Jul99] Pethidine: A. Norpethidine metabolite B. Pethidine 6-glucuronide OP19 [Jul01] [Jul04] Alfentanil works faster than fentanyl because: A. More lipid soluble B. Higher concentration unbound, unionised at physiological ph C. Decreased protein binding D. Larger volume of distribution OP20 [Jul00] [Apr01] Methadone: A. Phenanthrene derivative C. Peak plasma levels at 3 hours (true after oral administration) D. Used in chronic cancer pain due to non-addictive potential E. D-isomer provides analgesic effects (L-isomer does) OP21 [Apr01] Tramadol: A. Has beta blocking properties B. Blocks noradrenaline reuptake C. Has greater opioid activity than morphine D. Is directly inhibited by yohimbine E. Only the (+)-enantiomer is active OP22 [Jul01] The most unlikely thing to occur with morphine administered in recovery is: A. Constipation B. Respiratory depression C. Sedation

D. Nausea and vomiting E. Physical dependance F. Pruritis OP24 [Jul01] Extrahepatic de-esterfication of remifentanil A. Occurs in RBC B. By Plasma Cholinesterase C. NOT in incubated blood D. Has (?mean) clearance less than 1L/min E. Has an active metabolite OP25 [Jul01] The following are metabolites of morphine except: A. Morphine-6-glucuronide B. Morphine-3-glucuronide C. Normorphone D. Codeine E. Hydromorphine OP26 [Jul01] Fentanyl given at dose of 50-150 mcg/kg: A. Causes potent cardiac depression B. Does not cause muscle rigidity C. Has an elimination half-time of more than 3 hours D. Not enough to relieve the stress response to surgery E. Preserve cardiac output OP27 [Jul04] Prolonged duration of action of morphine in renal failure is due to A. Morphine 3-glucuronide B. Morphine 6-glucuronide C. Metabolism of morphine OP28 [Jul-06] Which is NOT a side effect of morphine: A. Seizures B. Mydriasis C. Respiratory depression D. Histamine release OP29 When clonidine is added to local anaesthetic in a peripheral nerve block, its actions are as the results of: A. Supraspinal Effect B. Spinal effect C. Effect on primary afferent nerves at the site D. Clonidine has no effect in peripheral nerve blocks E. Can cause neurotoxicity OP30 Which of the following opioids have INACTIVE metabolites? A. Oxycodone B. Morphine C. Pethidine D. Methadone E. Codeine

OP31 Naloxone: E. Refractory respiratory depression may occur with a single dose OP32 Buprenorphine: A. Transdermal is used as an effect acute pain strategy B. Plasma concentration rises rapidly when injected IV C. Maybe an option to do with its pka D. Semi-synthetic derivative of thebaine OP33 Which is most true regarding Pethidine? A. Pethidine affects serotonin reuptake B. Pethidine causes less nausea and vomiting than morphine OP34 Naltrexone: A. Partial mu antagonist B. Reverses the effect of a heroin o/d for 72 hours (duration of action ~ 24 hrs) C. One isomer only D. Absorbed well across small intestine into portal vein E. Is only effective for the treatment of opioid addiction OP35 Decreased effect of a dose of opioid in a chronic narcotic abuser would be best described as: A. Tolerance B. Tachyphylaxis C. Addiction OP36-15A Regarding pethidine's metabolite, norpethidine: A. elimination half-life is shorter than pethidine B. stimulates the CNS C. analgesic effect twice that of pethidine D. responsible for most of the analgesia of pethidine E. not excreted in the urine OP37-15A Alfentanil elimination half-life is prolonged in: A. hypoalbuminaemia B. administration of erythromycin C. caucasian children D. renal failure E. slow acetylators OP38-15A Buprenorphine: A. henbane derivative B. low lipid solubility C. high Mu affinity D. little first pass metabolism E. less potent than morphine OP39-15A Pharmacokinetics of fentanyl is most affected by: A. Variability in age

B. Renal disease C. Type of surgery D.? E. Liver flood flow/disease OP40-15A The context sensitive half-time of alfentanil in a 37yo woman undergoing a 4 hour operation would be closest to: A. 4 minutes B. 10 minutes C. 30 minutes D. 60 minutes E. 120 minutes OP41-15A With regards to opioid metabolism which of the following is true? A. Primarily reductive hepatic metabolism of phenylpiperidine derivatives B. Morphine, tramadol, and hydromorphone are metabolised to active metabolites C. Codeine, oxycodone and tramadol are metabolised by CYP2D6 to active metabolites D. Pethidine, tramadol and oxycodone have metabolites with seizure-like activity